| Peripheral embolism due to bone entrapment of the popliteal artery after valgus osteotomy: a case report. | |
| | |
MedLine Citation:
|
PMID: 17494852 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The authors report on a case of arterial embolism caused by bone entrapment of the popliteal artery due to a protrusion of a hydroxyl-apatite wedge. The wedge had been placed 4 years earlier during the course of a valgus osteotomy procedure. Thrombolytic therapy was performed, and the wedge was removed. Because causes for arterial embolism vary, the knowledge of its underlying mechanism is necessary to avoid recurring events. Bone entrapment after knee surgery is a differential diagnosis that should be taken into account, even years after surgery. |
| | |
Authors:
|
Kilian Rittig; Michael Fenchel; Nora Greipel; Hans-Ulrich Häring; Bernd Balletshofer |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of vascular and interventional radiology : JVIR Volume: 18 ISSN: 1051-0443 ISO Abbreviation: J Vasc Interv Radiol Publication Date: 2007 May |
Date Detail:
|
Created Date: 2007-05-14 Completed Date: 2007-06-28 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9203369 Medline TA: J Vasc Interv Radiol Country: United States |
Other Details:
|
Languages: eng Pagination: 677-80 Citation Subset: IM |
Affiliation:
|
Department of Endocrinology, Eberhard-Karls-University of Tuebingen, Otfried-Müller Strasse 10, 72076 Tübingen, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiography Arterial Occlusive Diseases / etiology*, radiography, therapy Biocompatible Materials / adverse effects Durapatite / adverse effects Embolism Female Fibrinolytic Agents / administration & dosage Humans Infusions, Intra-Arterial Middle Aged Osteotomy / adverse effects* Popliteal Artery* Thrombolytic Therapy Urokinase-Type Plasminogen Activator / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/Biocompatible Materials; 0/Fibrinolytic Agents; 1306-06-5/Durapatite; EC 3.4.21.73/Urokinase-Type Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dual use of an amplatzer device in the transcatheter embolization of a large high-flow renal arterio...
Next Document: Features influencing patient selection for fibroid treatment with magnetic resonance-guided focused ...